# Council Memo — 2026-09-07

*This is structured synthesis of your own agents' analysis over data fetched
this session. It is not licensed investment advice.*

**The lead this sweep is a record correction, not a market move.** ABB.ST's
stored `thesis_status` said WEAKENING while the Council had formally called
SELL twice (2026-08-24, reaffirmed 2026-08-31) and neither call executed. That
field was corrected to BROKEN this session. The important nuance, which no
single voice would have surfaced alone: **ABB's numbers are slightly *better*
this sweep than at the 2026-08-17 review** (P/E 37.3 → 35.3, PEG 2.71 → 2.11).
Nothing deteriorated. What changed is that the system finally wrote down a
decision it had already made twice. Read the ABB entry below as a rotation
call, not a distress call — the difference matters for how urgently it gets
executed.

Two other live items sit alongside it: the AZN.ST BUY from 2026-08-31 was
marked **expired** this session (a real 3-share purchase on 2026-08-25 that
predates the call spent the cash the call assumed), and the portfolio lens's
drawdown-tolerance row now reads **WATCH-unverified-not-OK**, not OK.

---

## 1. Position report

Snapshot: `20260907T061430.json` · previous: `20260907T061213.json`

| Position | Price | Δ vs prev snapshot | Δ vs cost | 52w range | Value (SEK) | Source |
|---|---|---|---|---|---|---|
| Handelsbanken A (stock) | 149.45 | no data | +15.6% | 96% | 149.45 | fetched |
| Investor A (stock) | 405.90 | no data | +39.9% | 91% | 2,029.50 | fetched |
| Volvo B | 348.30 | no data | -5.2% | 80% | 4,527.90 | fetched |
| Atlas Copco B | 174.70 | no data | -3.6% | 79% | 4,716.90 | fetched |
| AstraZeneca | 1,570.50 | no data | +2.1% | 37% | 12,564.00 | fetched |
| Xetra-Gold (physically-backed gold ETC, ISIN DE000A0S9GB0) | no data | no data | no data | - | 5,689.22 | FETCH FAILED |
| Alfa Laval | 555.20 | no data | -3.3% | 78% | 4,996.80 | fetched |
| ABB | 912.00 | no data | -3.7% | 65% | 3,648.00 | fetched |
| Avanza Auto 3 (fund) | no data | no data | +65.2% | - | 16,191.00 | book value |
| Avanza Global (fund) | no data | no data | +0.0% | - | 119,999.00 | book value |
| Valour Bitcoin Zero SEK (certificate, ISIN CH0585378661) | 47.29 | no data | -22.9% | - | 7,093.80 | fetched |
| ETH (self-custody wallet) | 24,036.36 | no data | no data | - | 12,062.65 | fetched (CoinGecko, converted via sek_per_eur) |

*52w range: 0% = at the 52-week low, 100% = at the 52-week high.*

| Coin | Price (EUR) | Δ vs prev snapshot | 7d | 30d | vs ATH |
|---|---|---|---|---|---|
| bitcoin | 68,713.00 | no data | +2.8% | +22.8% | -36.2% |
| ethereum | 2,159.95 | no data | +3.6% | +30.7% | -48.9% |

**Reading.** The `Δ vs prev snapshot` column is empty across the board because
the previous snapshot in this same session was a partial fetch — no
week-over-week move is measurable from this table, and I have not inferred
one. Against `candidate_history.csv` (2026-08-31 → 2026-09-07) the four
Swedish industrials all fell: ABB 938.40 → 912.00, ALFA 576.60 → 555.20,
ATCO-B 181.35 → 174.70, VOLV-B 346.40 → 348.30 (the exception, up 0.5%). None
of those moves is large enough to change a thesis, and none contradicts one —
ABB falling 2.8% is consistent with the SELL that was already called, not
evidence for it. **The position that matters is the one that did not move:**
AZN.ST at 1,570.50, unchanged from 1,571.50 last sweep, and still the only
holding trading in the lower half of its 52-week range (37%) while everything
else sits at 65–96%. Crypto is up 22.8%/30.7% over 30 days, which is what
pushed the crypto sleeve to 10.30% against a 10% target. The index funds
(Avanza Global 53.6% of total, Auto 3 7.2%) are carried at book value dated
2026-07-28 and 2026-07-24 — see the data-quality flag in section 4.

---

## 2. Scout health

```
Universe:   624
Fetched:    624   (cache 0, new 625, failed 1)
Ranked:     614
Candidates: 74  (holdings 9, watchlist 30, new 35)
Focus:      23
Screened:   74
Passed:     40
Missing:    18
Failed:     16
Status: VALID
```

**Reading, and one correction to how "new" reads.** Status is VALID and 35
rows carry `source=new`, so this is not a sweep that failed to search. But
`new` means *not held and not watchlisted* — it does **not** mean *first seen
this sweep*. Diffed against `data/candidate_history.csv`, only **three names
are genuinely new to the candidate file**: BURE.ST, EIX, HON. TEL2-B.ST
returned after a one-run absence; three names left (EXE, ZTS and one other).
The top of the funnel is essentially frozen — APP has been rank 1 for three
consecutive runs, SNDK rank 2 three times, NVDA rank 3 three times, and the
entire top 15 is the same set of names as 2026-08-31 in near-identical order.
That is a Pillar-1 (Discovery) observation worth recording plainly: turnover
is happening at ranks 40–70, not at the top. It is not yet a failure — three
runs is not a trend — but a fourth sweep with an unchanged top 10 would be.

One rank move breaks the pattern and is named below: **AVGO 22 → 12**, the
largest move in the focus set, achieved while the price *fell* 371.54 → 357.16.

Suspect values withheld from scoring this run: ABB.ST `price_to_book=104.57`,
INDU-C.ST/SNDK/MU `revenue_growth`, ASML `price_to_book`/`roic`, KINV-B.ST
`price_to_sales`, CMCSA/FANG `peg`. Two of those sit on the funnel's #2 and #4
names (SNDK, MU) — handled correctly below.

---

## 3. Top opportunities

### #1 OPPORTUNITY: ABB.ST — ABB Ltd

**CATEGORY:** holding
**RANK HISTORY:** current 66, previous 64 (2026-08-31), 64 (2026-08-25) — in
the candidate set 3 of 3 runs, never in the top 10; ranked 64–66 every time.
**VOICES IN FAVOR (of SELL):** Quality: 7, FCF yield 0.09% against a 35.3x P/E
means you are paying a premium multiple for cash generation that barely
exists; Valuation: 7, P/E 35.3 with forward P/E 34.76 — flat, so the market
itself prices no re-rating; Growth: 6, 14.2% ttm revenue growth with a *flat*
forward multiple is a margin-compression signal, not a growth signal.
**VOICES AGAINST / CAUTIOUS:** Defensive: the balance sheet is fine
(net_debt/EBITDA 0.46, D/E 55.8) so this is not a risk-driven sale and I will
not pretend it is; Copycat: **no new insider signal — the 4 disposals in this
sweep's FI pull are byte-for-byte the same transactions already recorded
2026-08-23** (Terwiesch 18,799 + 10,000 + 20,000 = 48,799 shares, 29/07–13/08,
plus Meline 2,456 on 05/08). Zero new disposals in 15 days. The 6 "acquisitions"
are all board members on 04/05/2026 at an identical 78.42 CHF — an annual board
allotment, not conviction buying.
**STRONGEST CASE FOR:** Quality's FCF yield of 0.09%. Every other objection to
ABB is a matter of degree; this one is a matter of kind. At a 35.3x multiple
the position is being valued entirely on future earnings, and the current cash
conversion gives no evidence they arrive.
**STRONGEST CASE AGAINST:** Copycat's. The insider-selling clause of ABB's own
break condition has now tested **negative twice** (2026-08-23, and again
today). A voice reading transaction *counts* rather than transaction *identity*
would have scored this as fresh confirming evidence. It is not. The SELL has to
stand on valuation alone, and it does — but with one fewer leg than the record
implies.
**KEY DISAGREEMENT:** Is "BROKEN" a fact about ABB or a fact about this
system's record-keeping? The honest answer is: **partly the latter.** P/E fell
37.3 → 35.3 and PEG fell 2.71 → 2.11 since the 2026-08-17 review. Nothing about
ABB got worse. The status changed because the break condition's
"better-positioned alternative surfaces" clause has been satisfiable for three
sweeps and the field was never updated. That does not make the SELL wrong; it
makes it non-urgent, and mislabelling a stale decision as a fresh deterioration
would be the exact failure this system exists to prevent.
**DATA GAPS:** ABB's `price_to_book=104.57` is suspect-flagged and withheld
from scoring — correctly, the FX-corrected figure in
`data/company_profiles/ABB.ST.json` is ~11.7x. Nothing in the SELL case rests
on it. No EV/EBIT is computed by this system; net_debt/EBITDA 0.46 is the
approximation used and it is stated as an approximation.
**CHAIRMAN CONVICTION:** 7
**WHAT WOULD CHANGE THIS:** A forward P/E that falls materially below trailing
in the next print — that would say the market has started pricing the 14.2%
revenue growth into earnings, and the margin-compression read would be wrong.
**PORTFOLIO FIT:** portfolio's read, quoted: "Equity sector concentration ACT
(Industrials 54.8% of the picked-stock sleeve: VOLV-B.ST+ATCO-B.ST+ALFA.ST+
ABB.ST)" and "Correlated-industrial concentration (54.8% Industrials) can only
be fixed by trimming an existing name (ABB rotation, not by candidate selection
— none of the 14 focus new names are industrials)." Also: "If/when ABB.ST
rotation executes, portfolio-fit constraint for proceeds: something outside
Industrials, outside Sweden, and ideally not just relabeling as semiconductors."
This is the only lever available to move an ACT-rated dimension.
**FINAL CALL: SELL** — all 4 shares, ~3,648 SEK at 912.00. Third consecutive
sweep. No tax event (ISK).
**HORIZON:** Medium (6mo–3y)

---

### #2 OPPORTUNITY: AZN.ST — AstraZeneca

**CATEGORY:** holding
**RANK HISTORY:** current 61, previous 60, 59 — in the candidate set 3 of 3
runs, never in the top 10 (the mechanical funnel does not like it; the voices
do, and that gap is itself the finding).
**VOICES IN FAVOR:** Macro: 7, SEK-listed access with USD/EUR revenue is a
genuine tailwind at DXY 118.75, and Swedish disinflation (CPI 0.2% vs a 1.75%
policy rate, a ~+1.55% real rate) makes a low-beta SEK-listed defensive more
valuable, not less; Defensive: 7, **beta 0.205 is the lowest of any name in the
entire 74-row candidate set**, net_debt/EBITDA 1.38, and it is the holding best
positioned for the downside I am actually worried about (an AI-capex unwind
with rates staying high); Valuation: 6, PEG 1.26 — better than the 1.33 at
purchase — and the only holding trading in the lower half of its 52-week range.
**VOICES AGAINST / CAUTIOUS:** Growth: 6.4% ttm revenue growth against a 9.8%
three-year CAGR is deceleration, and the PEG only looks good because the P/E is
moderate, not because growth is strong; Quality: FCF yield 0.20% and ROIC 13.1%
are unremarkable — this is a solid business, not an excellent one, and I will
not call it excellent because it is comfortable; **Copycat: the insider record
does NOT support this call.** Of AZN's five FI "acquisitions", the March 2026
entries are paired Allotment/Acquisition rows priced at **0.00 GBP** — that is
share-plan vesting, no cash changed hands. CFO Sarin's 11,133 shares (17/08/2026)
and CEO Soriot's 18,359 (14/05/2026) are also priced 0.00. Read by direction
alone this looks like insider buying; read by quality and context it is
compensation. Copycat's verdict on AZN.ST is **no signal**, not support.
**STRONGEST CASE FOR:** Defensive's. Beta 0.205 in a book whose picked-stock
sleeve is 54.8% industrials and whose largest single risk is a correlated
industrial-cycle bet. This is the only holding that does a different job from
the others.
**STRONGEST CASE AGAINST:** Growth's deceleration read, sharpened by Quality's
0.20% FCF yield. A pharma decelerating from 9.8% to 6.4% with thin free cash
flow is being bought for its beta, not its business — and paying up for low beta
is still paying up.
**KEY DISAGREEMENT:** Valuation and Defensive want more of it; Growth and
Quality say the business is merely adequate and the case is really a
portfolio-shape argument wearing a stock-picking costume. Both are right. The
resolution is that a portfolio-shape argument is a legitimate reason to add to
an INTACT thesis — but it caps the size, and it means this is not a
high-conviction stock call.
**DATA GAPS:** **No forward P/E for AZN.ST** — the S21 Swedish-listing coverage
gap, live on this exact name. The PEG 1.26 that three voices cite rests on a
trailing P/E and a growth estimate, with no forward multiple to cross-check.
That is a real discount to confidence. No earnings-revision data exists in this
system to test the deceleration.
**CHAIRMAN CONVICTION:** 6
**WHAT WOULD CHANGE THIS:** The next reported quarter showing revenue growth
below ~5% or a margin step-down — either fires break condition one and moves the
thesis off INTACT.
**PORTFOLIO FIT:** portfolio's read, quoted: "Single-position OK (AZN.ST largest
true security at 5.6%)" and "Asset allocation WATCH (equity 72.45% vs 80%,
-7.55pp/-16,908 SEK)". Equity is underweight by ~16,908 SEK, so an add is
directionally correct against the target; and "REBALANCING: no sales needed to
close drift... route new contributions + the P3 PayPal conversion (~14,268 SEK,
no tax event, cash deposit not disposal) toward equity/gold." AZN.ST at 5.6% is
comfortably inside the 15% single-position cap.
**FINAL CALL: BUY** — 1 share at ~1,570.50 SEK.
**EXECUTION NOTE — capital verified against this sweep's portfolio output:**
ISK cash is **845.43 SEK**. That is not enough for one share. The only free
capital is the **~14,268 SEK PayPal balance (P3), unrouted for a fifth
consecutive sweep.** This call is BUY on merit with funding pending P3, not
WATCH — but do not repeat the 2026-08-31 error: that call was marked *expired*
this session precisely because it assumed 11,288 SEK of cash that had already
been spent. The 845.43 SEK figure above is this sweep's confirmed number.
**HORIZON:** Long (3y+)

---

### #3 OPPORTUNITY: VICI — Vici Properties

**CATEGORY:** new candidate (not held, not watchlisted; first appeared in the
candidate file 2026-08-25)
**RANK HISTORY:** current 9, previous 8, 8 — **three consecutive top-10
finishes.** Open unexecuted BUY on the ledger since 2026-08-31 (conviction 6).
**VOICES IN FAVOR:** Valuation: 7, P/E 9.85 / forward 8.50 with a 7.24%
dividend at 4% of its 52-week range — the cheapest name in the set that is not
cheap because its revenue is shrinking (revenue +5.7%, 3y CAGR +15.5%);
Contrarian: 6, the market is pricing VICI as a rate instrument, and with the
10-year at 4.77% and the 10y–2y curve at +0.43 most of the rate repricing has
already happened — the rent does not care about the discount rate, the multiple
does.
**VOICES AGAINST / CAUTIOUS:** **Macro: explicit downgrade on regime grounds,
stated plainly rather than buried in a score.** net_debt/EBITDA 4.82 at a 4.77%
long rate, with a +0.43 curve signalling no recession and therefore no rate
relief priced, is exactly the profile that de-rates in this regime. Quality: ROIC
4.8% and ROE 9.8% describe a rent-collection vehicle, not a compounder — the
real quality question is tenant concentration and **no fetched field covers it**;
Copycat: **MISSING — zero insider read.** SEC EDGAR returned
`Tunnel connection failed: 403 Forbidden` on the CIK mapping fetch. This is the
**second consecutive sweep** the Copycat voice has been blind on VICI
specifically, and S25 named this exact name last sweep.
**STRONGEST CASE FOR:** Contrarian's — that the rate repricing is behind rather
than ahead, evidenced by the curve at +0.43 rather than asserted.
**STRONGEST CASE AGAINST:** Macro's — the same +0.43 curve that Contrarian reads
as "repricing done" also means no cuts are priced, so the 4.82x leverage
refinances into a rate that is not falling. **These two voices are reading the
same number in opposite directions and I am not going to average them.** The
curve is genuinely ambiguous here: it says no recession, which is good for the
tenant and bad for the multiple, simultaneously.
**DATA GAPS:** No EV/EBITDA is computed by this system — net_debt/EBITDA 4.82 is
the approximation and is labelled as such. No AFFO, so the 9.85x P/E overstates
cheapness for a REIT (depreciation is a non-cash charge on assets that do not
depreciate economically). No tenant-concentration or lease-duration field. No
insider data. Confidence discounted to **medium-low** on the accumulation of
these.
**CHAIRMAN CONVICTION:** 6 (unchanged from 2026-08-31 — the case neither
strengthened nor weakened; price 25.77 → 25.65, rank 8 → 9)
**WHAT WOULD CHANGE THIS:** The US 10-year moving decisively through 5% (kills
it) or below 4.25% (makes it a much larger position). FOMC is 2026-09-15/16 —
see section 8.
**PORTFOLIO FIT:** portfolio's read, quoted verbatim: "**VICI and TPL are the
only two candidates opening genuinely new sectors (Real Estate, Energy) with
zero current exposure.**" And on the funding constraint: "If/when ABB.ST rotation
executes, portfolio-fit constraint for proceeds: something outside Industrials,
outside Sweden, and ideally not just relabeling as semiconductors." VICI
satisfies all three clauses exactly. TPL, the only alternative that opens a new
sector, was ruled unreliable by valuation (forward P/E 4.96 against a trailing
46.29 — a 9.3x ratio that is not credible) and screens FAIL.
**FINAL CALL: BUY — as the second leg of the ABB rotation, not as a standalone
purchase.** ~15 shares from the ABB proceeds (3,648 SEK) plus the SHB-A share
(149.45 SEK): ~3,797 SEK at 25.65 USD × 9.5949 SEK/USD ≈ 246.11 SEK/share.
**If ABB does not sell, there is no VICI** — 845.43 SEK of ISK cash funds
nothing. Naming this as one linked transaction rather than two independent calls
is deliberate: the destination for these proceeds has churned GOOGL → META →
VICI across three sweeps without the first leg ever executing. Holding it at VICI
for a second consecutive sweep stops that churn; re-arguing the destination a
fourth time would be the failure.
**HORIZON:** Medium (6mo–3y)

---

### #4 OPPORTUNITY: VOLCAR-B.ST — Volvo Car AB

**CATEGORY:** new candidate (not held, not watchlisted) — **and the only name
this sweep that reached the Top 5 from outside the focus set**, pulled in
independently by two voices.
**RANK HISTORY:** current 43, previous 41, 41 — present all 3 runs, never
focus, never top 30. The mechanical funnel does not rank it; the insider
evidence does.
**VOICES IN FAVOR:** **Copycat: 6 — the strongest genuine smart-money signal in
this sweep, and it lands on a candidate rather than a holding.** Three separate
Volvo Car insiders made open-market acquisitions in the last two months, all
priced **above** today's 18.70 SEK: CEO Håkan Samuelsson 50,000 sh @ 19.295
(17/07/2026), board member Pieter Nota 63,000 sh @ 19.60 (12/08/2026), senior
executive Erik Severinson 15,306 sh @ 19.00 (17/07/2026). Several insiders moving
independently is a materially different signal from one insider moving
repeatedly. Contrarian: 6, at **2% of its 52-week range** — effectively the low —
with D/E only 30.8 and net_debt/EBITDA 0.22. The specific reason the pessimism
looks wrong: the market is reading revenue -16.9% and negative free cash flow as
terminal, but this is **margin distress, not balance-sheet distress**, and the
two have very different recovery paths.
**VOICES AGAINST / CAUTIOUS:** Quality: net margin 2.8%, ROIC 1.1%, ROE 3.6% —
by any measure this is a bad business, and three insiders buying does not change
an income statement; Defensive: **FCF yield -26.92%** — the company is burning
cash equal to a quarter of its market capitalisation annually, which is a
financing question, not a valuation question; Growth: revenue -16.9%; Macro: a
Swedish consumer cyclical facing a ~+1.55% real policy rate, with a Riksbank
decision on 2026-09-24; Valuation: screen status **MISSING** — no forward P/E,
the S21 Swedish coverage gap, so this name is ranked on fewer fields than any US
peer and cannot be compared like-for-like.
**STRONGEST CASE FOR:** Copycat's. Three independent insiders including the CEO,
all paying more than today's price, is the highest-quality insider pattern
anywhere in this sweep's data — higher than Handelsbanken's much larger number,
because those were connected-entity block transactions and these are separate
people acting separately.
**STRONGEST CASE AGAINST:** Defensive's. A -26.92% FCF yield means the balance
sheet that looks clean today (net_debt/EBITDA 0.22) is being consumed. Insiders
buying at 19–19.60 does not tell you they know the cash burn stops; it tells you
they think it does.
**KEY DISAGREEMENT:** Copycat says three insiders know something the price does
not reflect. Defensive says a company burning 26.92% of its market cap in cash
does not need insiders to explain its price — it needs a financing plan, and
neither the insiders nor this system can supply one. Unresolved, and correctly
so.
**DATA GAPS:** No forward P/E (S21). No organic revenue detail. Geely's majority
control means minority-shareholder influence is limited — qualitative, not
fetched. Note for the record: the FI query for issuer "Volvo" returns **both AB
Volvo and Volvo Car AB**; a careless read would attribute these purchases to the
VOLV-B.ST holding. They belong to Volvo Car.
**CHAIRMAN CONVICTION:** 4
**WHAT WOULD CHANGE THIS:** A quarter showing free cash flow turning
less-negative. That single observable separates "margin distress, recoverable"
from "structural cash burn". Until it appears, the insider signal is a reason to
watch, not to buy.
**PORTFOLIO FIT:** portfolio's read: "Geography WATCH (Sweden 50.3% of
known-sector sleeve)" — adding a Swedish name works against an already-flagged
dimension. Also: "Entire candidate pool is 100% large-cap (smallest EG at
$14.6B) — portfolio's standing zero-mid/small-cap gap (V2 Phase 4) is untouched
by any candidate this sweep." VOLCAR-B at 55.9B SEK (~5.8B USD) is the closest
thing in the set to a non-mega-cap, which is a genuine point in its favour that
the portfolio lens's own text does not capture.
**FINAL CALL: HOLD-WATCH** — add to `data/watchlist.json` so it is screened
every sweep rather than surfacing by accident at rank 43. No capital committed.
**HORIZON:** Medium (6mo–3y)

---

### #5 OPPORTUNITY: AVGO — Broadcom

**CATEGORY:** watchlist
**RANK HISTORY:** current 12, previous 22, 21 — **the largest rank move in the
focus set this sweep, achieved while the price fell** (371.54 → 357.16).
z_quality rose 0.941 → 1.230 and z_growth 1.632 → 1.782 on a falling price.
**VOICES IN FAVOR:** Growth: 6, revenue +85.5% ttm against a 24.4% three-year
CAGR — measured acceleration of 3.5x, the sharpest among large caps once the
suspect-flagged memory names are excluded; Valuation: 6, forward P/E 18.47
against trailing 45.65 is the widest forward/trailing compression of any credible
name in the set, PEG 0.35; Contrarian: 5, at 33% of its 52-week range while its
own forward estimate improves — price and estimate moving in opposite directions
is the specific contrarian condition, not just "it fell".
**VOICES AGAINST / CAUTIOUS:** **Growth undercuts its own pick** — a large share
of that 85.5% is the VMware acquisition, and **no field in this system separates
organic from inorganic revenue.** If the acceleration is mostly acquired, the
PEG 0.35 is an artifact; Quality: screen FAIL on trailing P/E 45.65; Macro: DXY
118.75 means buying USD assets here buys the currency at a historically strong
level as well as the equity, an unchosen FX position for a SEK-based investor;
Copycat: **MISSING — EDGAR blocked**, no insider read; Portfolio: quoted —
"APP/SNDK/NVDA/MU/TSM/AVGO/SMCI all in a semiconductor/AI-hardware cluster —
buying several together swaps Industrials concentration for a new correlated
cluster, doesn't fix it."
**STRONGEST CASE FOR:** Valuation's forward/trailing compression, corroborated by
a rank that rose on a falling price. Two independent measures moved the same way.
**STRONGEST CASE AGAINST:** Growth's own caveat, which is the deciding fact of
this entry. The entire bull case is a forward estimate; the quality of that
estimate depends on whether the revenue acceleration is organic; **this system
cannot inspect that.** Underwriting a PEG of 0.35 that I cannot decompose would
be exactly the confident-structure-on-uninspectable-input failure this system
exists to prevent.
**KEY DISAGREEMENT:** Valuation treats the forward estimate as evidence; Growth
treats it as a hypothesis it cannot test. That is not a difference of degree —
it is a disagreement about whether the central number is admissible.
**DATA GAPS:** No organic/inorganic revenue split. No EV/EBITDA. No insider data
(EDGAR 403). No earnings-revision history to see whether that forward estimate is
rising or falling.
**CHAIRMAN CONVICTION:** 5
**WHAT WOULD CHANGE THIS:** One reported quarter far enough past the VMware
close that the year-over-year comparison is organic. That is a date, not a
judgement, and it resolves the entire question.
**PORTFOLIO FIT:** portfolio's read, quoted: "buying several together swaps
Industrials concentration for a new correlated cluster, doesn't fix it." AVGO is
the best name in that cluster on this sweep's numbers, and the cluster is the
wrong shape for this book. Both are true.
**FINAL CALL: HOLD-WATCH** — no action. Recorded so that when the organic
comparison lands, the reasoning is on file rather than re-derived.
**HORIZON:** Medium (6mo–3y)

---

### Other SELL recommendations on current holdings

**SHB-A.ST — Handelsbanken A. Three voices flag SELL. I am calling HOLD, and
the reason is not conviction — it is size.**

This is the sweep's sharpest genuine conflict and it deserves stating rather
than resolving.

- **Against the holding:** revenue -3.8% YoY; PEG 18.85; **forward P/E 13.22 is
  ABOVE trailing 12.60**, meaning consensus expects earnings to *fall*; price at
  **96% of its 52-week range**; z_growth -1.267, the worst in the focus set;
  thesis WEAKENING; thesis-review's own verdict is "Buy today: NO — THESIS".
  Valuation SELL conviction 7, Growth SELL 6, Contrarian SELL 5.
- **For the holding:** the largest single insider transaction anywhere in this
  sweep's data. Chairman **Pär Boman, 1,850,000 shares across 10 line items, all
  Acquisitions, all executed on one day (2026-08-26)** at 145.55–146.24 SEK —
  roughly **270 million SEK**. Zero disposals. The FI page is capped at 15
  results and returned 10, all from that single day, so this is the visible
  portion, not necessarily the whole.
- **Copycat's own qualification, which is the part that matters:** every one of
  those rows carries `Closely associated: Yes`. The acquiring party is an entity
  connected to Boman, not his personal account, and 1.85M shares in one day
  inside a 0.7-SEK price band is the signature of a **block or structural
  transaction** — Boman chairs both Handelsbanken and Industrivärden, and
  Industrivärden is Handelsbanken's largest owner. That is a genuine signal that
  a controlling block is adding. It is **not** the same signal as a CEO buying
  with his own money because he thinks the stock is cheap, and reading it as the
  latter would be exactly the direction-over-context error council.md warns
  against.
- **The deciding fact:** today's price of 149.45 is **above every single share
  the insider bought.** Copying the trade means paying more than the insider did,
  for a bank whose own forward estimate says earnings fall.

**FINAL: HOLD, conviction 5.** Not because the SELL case is weak — it is the
better-evidenced side — but because the position is **1 share, 149.45 SEK.**
Spending a decision and a courtage on 149 SEK is not risk management. It rides
along with the ABB sale as part of the same rotation order (see #3) or it does
nothing. What I will not do is record it as a hold *on the merits*, because on
the merits three voices want it gone.

**No other holding drew a SELL flag from any voice.** ATCO-B.ST and ALFA.ST both
drew "expensive, do not add" (PEG 1.93 and 2.36; thesis-review "HOLD ONLY" on
both) — that is a no-add, not a sell. VOLV-B.ST drew a Defensive objection to
*sizing* (D/E 147.3, net_debt/EBITDA 3.8, the most levered holding and a
cyclical) but not to ownership: it is 5 weeks into a stated TOO_EARLY thesis and
selling that fast would make the thesis untestable. INVE-A.ST is covered under
D-b in section 6.

**One finding on ALFA.ST that changes nothing today but will matter:** ALFA's
recorded thesis leans on "10/10 insider buys with zero sells" as its strongest
support. This sweep's FI pull confirms 9 acquisitions / 0 disposals — but **every
visible transaction is dated 2023–2024** (most recent 11/09/2024). The buying did
not reverse; it **stopped, roughly two years ago.** ALFA's break conditions cover
a disposal breaking the pattern; they do not cover the pattern simply going
quiet. That is a gap in the break condition, not a reason to sell.

---

## 4. Portfolio health scorecard

Carried verbatim from this sweep's `portfolio` output:

| Dimension | Status | Detail |
|---|---|---|
| Asset allocation | **WATCH** | equity 72.45% vs 80% (-7.55pp / -16,908 SEK); cash 11.81% vs 5% (+6.81pp); gold 2.54% vs 5% (-2.46pp); crypto 10.30% vs 10% OK |
| Equity sector concentration | **ACT** | Industrials 54.8% of the picked-stock sleeve (VOLV-B + ATCO-B + ALFA + ABB) |
| Geography | **WATCH** | Sweden 50.3% of known-sector sleeve |
| Currency | **WATCH** | liability currency undetermined |
| Single-position | **OK** | AZN.ST largest true security at 5.6%; Avanza Global 53.6% of total flagged for transparency, not a breach — diversified index |
| Institution concentration | **ACT** | Avanza 83.2% vs 80% cap, over by ~3.2pp / ~7,177 SEK, structural/ISK-driven |
| Fee drag | **OK** | ~187 SEK/yr = 0.084%, well under the 0.4% cap |
| Wrapper efficiency | **WATCH** | clean ISK/AF-wise; real open cost is P3 PayPal routing still unexecuted 5th+ sweep, ~14,268 SEK unwrapped, ~571 SEK one-time conversion friction |
| Drawdown-tolerance fit | **WATCH-unverified-not-OK** | S26: the only backtest's window never contained a real ≥30% shock. portfolio ran its own stress arithmetic — **NOT a backtest, labeled as such** — showing -35% equity / -75% crypto / -10% gold could produce ~**-36%** on the current 80/10/5/5 weights, past the -30% tolerance on non-extreme assumptions. Recommends keeping the 80/10/5/0/5 target as-is but prioritizing crypto-sleeve discipline over changing the target; S26 should close with a real shock-window backtest before this row is ever marked OK. |

**LEADING DATA-QUALITY FLAG (portfolio's own, carried):** Avanza Global (53.6%
of total) and Avanza Auto 3 (7.2%) have not been repriced in 6+ weeks
(`market_value_as_of` 2026-07-28 and 2026-07-24). **Every weight and drift
number in the table above inherits this staleness** — including the -7.55pp
equity underweight that justifies the AZN.ST add.

**`investor_profile.json` TBDs that make this scorecard provisional:**
- `horizon.primary_goal` is UNCERTAIN and `years_until_needed` is "3-7 (SOFT)".
  Every drawdown and glidepath judgement rests on a goal the user has stated is
  not set.
- `horizon.currency_note`: the future liability may be EUR, not SEK. This is
  the direct cause of the Currency WATCH row, and it cuts both ways — it also
  voids the standing rationale for a SEK/Nordic tilt.
- `constraints.exclusions` is empty and no ESG data exists for any name, held or
  candidate.
- `planned_monthly_contribution_sek` is a range ("1000-3000"), so no contribution
  schedule can be planned against.

**A file-level divergence found this sweep, not previously flagged:**
`investor_profile.json.reference_targets` still reads equity 85 / crypto 10 /
cash 5 / FI 0 — **it was never updated for the 2026-09-02 gold carve**, while
`data/portfolio.json.targets` reads 80/10/5/0/5. Two files, one concept,
diverged for five days. Per CLAUDE.md's ownership table `portfolio.json` owns
targets and is what every number above uses, so nothing in this memo is wrong —
but the stale copy will mislead whichever agent reads it first. Named for `meta`
in section 9.

---

## 5. Headline calls

1. **SELL ABB.ST, all 4 shares (~3,648 SEK).** Third consecutive sweep, thesis
   now recorded BROKEN. It is the only lever that moves the ACT-rated 54.8%
   Industrials concentration. Note honestly: ABB's numbers improved slightly
   since the last review — this is a rotation, not an escape.
2. **BUY VICI with the ABB proceeds (~15 shares, ~3,797 SEK including the SHB-A
   share).** One linked order, not two decisions. Second consecutive sweep at
   this destination — the GOOGL → META → VICI churn stops here. Macro dissents
   explicitly on rate sensitivity; that dissent is recorded, not averaged away.
3. **BUY 1 share AZN.ST (~1,570.50 SEK) — funding blocked on P3.** ISK cash is
   845.43 SEK, verified this sweep. The PayPal conversion is the only route and
   it is unexecuted for the fifth sweep.
4. **Execute P3, the PayPal conversion (~14,268 SEK).** This is now the binding
   constraint on two of the three calls above. It has been decided since
   2026-08-17 and the merits have not been re-argued since; only the destination
   has changed.
5. **Drawdown-tolerance is no longer OK.** portfolio's own stress arithmetic puts
   the current 80/10/5/5 mix at ~-36% against a stated -30% tolerance. It
   recommends crypto-sleeve discipline over changing the target — and crypto is
   at 10.30% vs 10% after a +22.8%/+30.7% thirty-day move. This needs a decision
   (D-c, section 6), not a note.

---

## 6. Open actions vs open decisions

### Open actions — things to go do

| ID | Action | Status |
|---|---|---|
| **P3** | Convert the PayPal balance (1,177.49 USD + 266.88 EUR ≈ 14,268 SEK) at the accepted 4% spread and transfer to the ISK. Then zero the paypal holdings in `portfolio.json`. | decided 2026-08-17 — pending execution, **5th sweep** |
| **P9** | Delete the phantom AZN OPENING row in the Excel Transactions tab, per the workbook's own README. | open — blocks nothing today |
| **P10** | Confirm: one 5,000 SEK deposit or two? (`transactions.csv` carries 2026-08-17 and 2026-08-22; the real Avanza export shows only 2026-08-22.) | open — real money, not merged without you |
| **S6 / D-b** | Read Investor AB's NAV per share off the quarterly report or IR page, record it in `data/company_profiles/INVE-A.ST.json`. ~10 minutes of human work. | open — **4th consecutive sweep a voice reached a conclusion it could not act on** |
| **S26** | Run `backtest.py` over a fixed window containing a real ≥-30% equity shock. First verify whether it already supports `--start`/`--end`. | open |
| **S27** | Fix the scheduled task's stored prompt (outside this repo). Drop the Handelsbanken-wrapper framing; rewrite the reference_targets line. | opened this session |

### Open decisions — forks that need you to pick

**D-a — Where the ABB proceeds go.** *Resolved this sweep, second consecutive
sweep at the same destination.*
- **Option 1 — VICI (~15 sh, ~3,797 SEK).** Opens Real Estate, zero current
  exposure, satisfies all three of portfolio's proceeds constraints. Trade-off:
  Macro dissents — 4.82x leverage at a 4.77% ten-year, FOMC 8 days out.
- **Option 2 — hold the proceeds as cash.** Trade-off: cash is already 11.81%
  against a 5% target; this widens the WATCH.
- **Option 3 — a fourth re-argument.** Trade-off: three sweeps of churn have
  already cost more than any of the three destinations would have.
- **Chairman's pick: Option 1**, executed as one order with the ABB sale.

**D-b — INVE-A.ST, the unmeasurable holding.** *Fourth consecutive sweep the same
missing metric blocked the same voice.*
- **Option 1 — get the NAV number (S6, ~10 min).** Trade-off: costs ten minutes,
  ends a recurring drag permanently, and is the only option that makes the
  position testable.
- **Option 2 — sell on absence of evidence (5 sh, ~2,029.50 SEK).** Trade-off:
  the FI data this sweep argues directly against it — **CEO Christian Cederholm
  bought personally and repeatedly through 2026** (1,250 @ 339.00 on 02/02,
  3,000 @ 340.50 on 19/03, 2,500 @ 387.30 on 17/07 — rising prices, zero
  disposals, `Closely associated` blank so these are his own account), plus
  Ulrika Elfving 850 @ 411.55 on 01/09/2026, **above today's 405.90**. Selling
  into that would be selling on a data gap while insiders buy.
- **Option 3 — stop re-flagging it and hold.** Trade-off: the position becomes
  permanently un-reviewable; you own it without being able to say whether it is
  cheap.
- **Chairman's pick: Option 1.** Contrarian wants to sell it (91% of range, no
  measurable valuation); Copycat says the CEO is buying his own stock at rising
  prices. That is a real disagreement and the metric that settles it costs ten
  minutes to obtain.

**D-c — The crypto sleeve, now that drawdown-tolerance reads
WATCH-unverified-not-OK.** *New this sweep.*
- **Option 1 — trim crypto back toward 10.0% and stop it drifting.** Trade-off:
  portfolio's stress arithmetic assumes -75% on crypto; that assumption is what
  pushes the mix to ~-36% against a -30% tolerance. Cuts the tail. Counts against
  the user's stated 3y+ BTC/ETH conviction and against `profit_recycling_rule`
  only if proceeds are not routed to the secure tier.
- **Option 2 — leave it, run S26's real shock-window backtest first, decide after.**
  Trade-off: the honest sequencing (portfolio itself says the ~-36% figure is
  arithmetic, *not* a backtest), but it leaves the exposure unchanged through
  another Greed-driven leg (crypto Fear & Greed 71).
- **Option 3 — change the -30% tolerance in `investor_profile.json`.** Trade-off:
  moving the target to fit the portfolio rather than the reverse. Legitimate only
  if the tolerance was mis-stated, which nothing here suggests.
- **Chairman's pick: Option 2**, matching portfolio's own recommendation
  ("keeping the 80/10/5/0/5 target as-is but prioritizing crypto-sleeve
  discipline/rebalancing over changing the target"), with S26 as the gating item.

---

## 7. Cost of being wrong

| Call | Realistic SEK downside if wrong | Recoverable? |
|---|---|---|
| SELL ABB.ST (4 sh, 3,648 SEK) | Opportunity cost if ABB re-rates: a 20% missed move on 3,648 SEK ≈ **730 SEK**. No tax event (ISK). | Yes — fully. The position can be re-entered; nothing is destroyed. |
| BUY VICI (~15 sh, ~3,797 SEK) | A 30% drawdown ≈ **1,139 SEK**. Worse case, a major-tenant default (Caesars/MGM concentration, unmeasured by this system): -50% ≈ **1,899 SEK**. | Yes — 1.7% of capital at the -30% case. The 7.24% dividend partly offsets a flat-to-down multiple. |
| BUY 1 sh AZN.ST (1,570.50 SEK) | A 30% drawdown ≈ **471 SEK**. Beta 0.205 makes a 30% single-name drawdown unlikely absent a company-specific event (pipeline failure, dividend cut). | Yes. 0.7% of capital. |
| HOLD SHB-A.ST (1 sh, 149.45 SEK) | If the three SELL voices are right and it falls 25%: ≈ **37 SEK**. | Yes — immaterial, which is the reason for the hold. |
| Execute P3 (~14,268 SEK) | Known, accepted, one-time: **~571 SEK** at the confirmed 4% worst-case spread. | No — the spread is spent. But it recurs every ~2 months indefinitely if not executed, so **not** executing has the larger cumulative cost. |
| HOLD-WATCH AVGO / VOLCAR-B.ST | **0 SEK.** No capital committed. The cost is the opportunity if either runs before the deciding observable arrives. | n/a |

---

## 8. Timing collisions

`calendar` ran (`data/cache/calendar/20260907-events.json`).

- **No earnings collisions for any holding inside 45 days** — all holding
  earnings dates fall 2026-10-20 to 2026-10-30. Both trades above clear that
  window comfortably.
- **FOMC 2026-09-15/16 — 8–9 days out, and it collides directly with the VICI
  decision.** VICI carries net_debt/EBITDA 4.82 and is the one name in this memo
  whose thesis is explicitly rate-dependent; Macro's dissent is entirely about
  the path of the long rate. Flagged, not decisive: this system has no
  demonstrated short-horizon edge and timing a purchase around an FOMC would be a
  tactical call the horizon policy caps at Short/never-High-confidence. The
  honest framing is that the FOMC is when the VICI thesis becomes testable, not
  when it should be traded.
- **Riksbank rate decision 2026-09-24 — 17 days out.** Relevant to the ABB sale
  only as market noise (a Swedish-listed disposal), and materially relevant to
  VOLCAR-B.ST, which stays HOLD-WATCH anyway. Sweden is running a ~+1.55% real
  policy rate (CPI 0.2% vs 1.75%) against the US at ~+0.09% — the sharpest
  policy divergence in this sweep's macro data.
- **Calendar reliability caveat:** `macro_calendar.json` `last_verified`
  2026-08-03, **35 days stale**, and `unverified_sources` reports US and SE CPI
  release dates are missing entirely. The two dates above are carried from that
  file. Treat them as indicative, not confirmed.

---

## 9. Data gaps for `meta`

Surfaced, not fixed. Ordered by how much they cost a decision this sweep.

1. **SEC EDGAR is confirmed BLOCKED, not merely out of scope.** `insider_activity`
   returned `CIK mapping fetch failed: Tunnel connection failed: 403 Forbidden`.
   The Copycat voice had **zero insider read on every US-listed candidate** — APP,
   SNDK, NVDA, MU, MA, V, TSM, VICI, TPL, AVGO, EG, SMCI, APO, LLY, VRTX, CME,
   UHS, RDDT, GOOGL. **This is a different failure from S25.** S25 diagnosed a
   *fetch-scope* problem (US names never submitted) and proposed a second narrow
   `--insiders` pass after scout. **That fix would not have helped this sweep** —
   the CIK mapping fetch itself 403'd, so no scope change reaches the data. This
   converts S20's open question ("is `www.sec.gov` reachable through this
   proxy?") from untested to **answered: no**. Second consecutive sweep this gap
   landed on a Top-5 BUY (VICI).
2. **No organic-vs-inorganic revenue split.** This single missing field is what
   moved AVGO from BUY to HOLD-WATCH. It is the highest-value gap in the memo
   because it decided an outcome rather than merely lowering confidence.
3. **No EV/EBITDA or EV/EBIT anywhere in the system.** Valuation approximated
   with `net_debt_to_ebitda` on VICI, CATE.ST, BALD-B.ST, CHTR, FIS and EIX and
   said so each time. For the three Swedish property names (net debt/EBITDA
   10.85, 16.13, 15.52) the approximation is doing real work.
4. **NAV discount/premium (S6) — fourth consecutive sweep.** Blocked INVE-A.ST,
   INDU-C.ST and now BURE.ST, all three of which occupy high `z_value` ranks
   (1.192 / 1.325 / 1.483) for reasons that mean nothing. The value lens is not
   just silent on holding companies; it is **actively misranking them upward**.
5. **The suspect-value detector has a coverage hole.** It correctly flagged
   ASML's `roic` and `price_to_book`, but **did not flag TSM's `roic_pct` of
   183.7% or `fcf_yield_pct` of 32.85%** — both implausible for a
   capital-intensive foundry, and both feeding `z_quality` 1.926 and TSM's rank-7
   position. The Quality voice caught it manually and rested its TSM case on ROE
   40.0% and net_debt/EBITDA -0.77 instead. A detector that catches ASML but not
   TSM is calibrated on the wrong tail.
6. **`investor_profile.json.reference_targets` is stale** (85/10/5/0) against
   `portfolio.json.targets` (80/10/5/0/5) since the 2026-09-02 gold carve. Not a
   new source of truth, just an un-updated copy — but it will mislead the first
   agent that reads it.
7. **Swedish forward-P/E coverage (S21) decided a screen status this sweep.**
   VOLCAR-B.ST screens MISSING rather than PASS/FAIL purely for the absent
   forward multiple, and it is the one candidate with a genuine multi-insider
   signal. The aggregate US tilt this item describes stopped being theoretical
   here.
8. **No REIT-specific fields.** No AFFO, no tenant concentration, no lease
   duration. VICI's central risk is structurally unmeasurable by this system, and
   it is a Top-5 BUY.

---

## 10. Learning notes

- **An insider "Acquisition" priced at 0.00 is not a purchase.** AstraZeneca's
  FI record shows five acquisitions and one disposal, which by direction alone
  reads as insider support for the AZN BUY. Reading the rows: the March 2026
  entries are paired **Allotment / Acquisition** lines and the acquisitions are
  priced **0.00 GBP** — no cash moved. That is share-plan vesting. The CFO's
  11,133 shares and the CEO's 18,359 are the same. Copycat's honest verdict on
  AZN is *no signal*, which made the BUY rest on Defensive and Macro alone. If
  the voice had counted directions instead of reading prices, it would have
  manufactured a third supporting argument out of payroll.

- **The same transactions can be counted twice if you count rows, not
  identities.** ABB's four disposals this sweep are the identical Terwiesch
  48,799 + Meline 2,456 shares already recorded on 2026-08-23. A voice looking
  for confirmation of the SELL could easily have logged "4 disposals in the
  latest pull" as fresh evidence. The break condition requires the selling to
  *continue*; it has now tested negative twice. The SELL survives on valuation —
  but with one leg fewer than the file implies, and that is worth knowing before
  executing.

- **A 6.5x forward P/E on a memory maker is not cheap — it is the market pricing
  an earnings collapse.** SNDK and MU sit at ranks 2 and 4 with forward P/Es of
  6.57 and 6.56 and z_quality scores of 2.53 and 2.32, built on ROICs of 80.1%
  and 53.5%. Those returns are cycle-peak DRAM/NAND economics, not evidence of
  business quality. Both also carry suspect-flagged revenue growth (371.6% and
  345.7%), correctly withheld from scoring. The mechanical funnel is measuring
  where they are in a cycle and reporting it as quality. Same logic, inverted,
  applies to **ALL (Allstate)**: the lowest headline P/E in the set (5.20) sits
  against a *forward* P/E of 9.40 — its own consensus expects earnings to fall
  ~45%. Whenever forward P/E exceeds trailing (SHB-A 13.22 vs 12.60, NOVO-B
  13.68 vs 11.39, GOOGL 22.79 vs 16.97, ALL 9.40 vs 5.20), the headline low
  multiple is describing the past.

- **The scheduled prompt that launches this sweep was wrong about two things
  again, for the third time.** It asserted the Handelsbanken wrapper question is
  unresolved and must open this memo (it was resolved 2026-07-07 / 2026-08-03;
  `portfolio.json.open_structural_questions` is `null`), and that
  `investor_profile.json.reference_targets` are null (they were adopted
  2026-07-27 and written 2026-08-03). Both were checked directly against the
  files and both are false. Per the standing instruction left in
  `OPEN_ITEMS.md`'s own closed log after the second occurrence, **S27 was opened
  this session without further deliberation.** All three occurrences self-caught
  and produced no wrong action — which is exactly why it stayed unopened twice —
  but the failure mode being guarded against is the fourth one that doesn't get
  caught. The fix is outside this repository: the scheduler's stored text needs
  editing, which no agent here can do.

---

## Structural / non-stock decisions

**ACTION:** Execute the PayPal conversion and route the proceeds to the Avanza ISK.
**POSITION:** `paypal` account — 1,177.49 USD + 266.88 EUR ≈ **14,268 SEK** at this
sweep's `sek_per_usd` 9.5949 and `sek_per_eur` 11.1282.
**TARGET:** Avanza ISK cash, then deployed per calls #2 and #3 above.
**REASON:** Lever #2 (fee drag). The balance sits outside any wrapper, earns
nothing, and the ~750–1,000 EUR / ~2-month inflow keeps landing there. It is also
now the **binding constraint on the AZN.ST BUY** — ISK cash is 845.43 SEK, which
funds nothing.
**THESIS STATUS:** Decided 2026-08-17 (user selected Option A, direct conversion
at the accepted 4% worst-case spread, declining the Revolut test-transfer).
Unchanged.
**WHAT CHANGED:** Nothing about the decision. What changed is that it is now
blocking a stock call rather than sitting idle — this is the fifth consecutive
sweep, and the merits have not been re-argued once. Only the eventual destination
moved (GOOGL → META → VICI), which is a separate question (D-a) and is now
settled.
**BREAK CONDITION:** If PayPal's actual quoted spread comes in materially below
4%, the cost figure improves and nothing else changes. If a cheaper route
appears, re-evaluate — but not by delaying another sweep to look for one.
**CONFIDENCE:** High. This is a structural, arithmetic call with no market view in
it.
**HORIZON:** Long (3y+) — recurring, not a one-off.

*Levers 1–2 are otherwise structurally closed: all capital is in the ISK, fee
drag measures 0.084% against a 0.4% cap. Nothing broke this sweep, so nothing
further is reported on them.*

---

**Picks recorded to `data/picks/2026-09-07-picks.csv`.**
